22 May 2013
Keywords: prasugrel, trials, suspended, dosage, issues, japanese, drugmaker
Article | 29 October 2007
Japanese drugmaker Daiichi Sankyo and US counterpart Eli Lilly say that enrollment and dosing have been suspended in two small
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 October 2007
© 2013 thepharmaletter.com